首页> 外文期刊>European journal of clinical investigation >Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease
【24h】

Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease

机译:脂蛋白(a)和冠状动脉疾病患者中,脂蛋白(A)和低密度脂蛋白载脂蛋白B代谢后肝剂组

获取原文
获取原文并翻译 | 示例
           

摘要

Background Lipoprotein apheresis effectively lowers lipoprotein(a) [Lp(a)] and low-density lipoprotein (LDL) by approximately 60%-70%. The rebound of LDL and Lp(a) particle concentrations following lipoprotein apheresis allows the determination of fractional catabolic rate (FCR) and hence production rate (PR) during non-steady state conditions. We aimed to investigate the kinetics of Lp(a) and LDL apolipoprotein B-100 (apoB) particles in patients with elevated Lp(a) and coronary artery disease undergoing regular apheresis. Patients and methods A cross-sectional study was carried out in 13 patients with elevated Lp(a) concentration (500 mg/L) and coronary artery disease. Lp(a) and LDL-apoB metabolic parameters, including FCR and PR were derived by the fit of a compartment model to the Lp(a) and LDL-apoB concentration data following lipoprotein apheresis. Results The FCR of Lp(a) was significantly lower than that of LDL-apoB (0.39 [0.31, 0.49] vs 0.57 [0.46, 0.71] pools/day, P = 0.03) with no significant differences in the corresponding PR (14.80 [11.34, 19.32] vs 15.73 [11.93, 20.75] mg/kg/day, P = 0.80). No significant associations were observed between the FCR and PR of Lp(a) and LDL-apoB. Conclusions In patients with elevated Lp(a), the fractional catabolism of Lp(a) is slower than that of LDL-apoB particles, implying that different metabolic pathways are involved in the catabolism of these lipoproteins. These findings have implications for new therapies for lowering apolipoprotein(a) and apoB to prevent atherosclerotic cardiovascular disease.
机译:背景技术脂蛋白血吸虫有效地降低了脂蛋白(A)[LP(A)]和低密度脂蛋白(LDL)约60%-70%。 LDL和LP(A)颗粒浓度的反弹脂蛋白血泡性血液凋亡后允许在非稳态条件下测定分数分解代谢率(FCR)并因此产生生产率(PR)。我们旨在探讨LP(a)和LDL载脂蛋白B-100(Apob)粒子的患者患者升高的LP(a)和冠状动脉疾病患者中的患者的动力学。患者和方法在13例升高的LP(a)浓度(& 500 mg / L)和冠状动脉疾病患者中进行横截面研究。 LP(A)和LDL-APOB代谢参数,包括FCR和PR的液体模型与LP(A)和LDL-APOB浓度数据的拟合衍生出脂蛋白素筛席后的LP(A)和LDL-APOB浓度数据。结果LP(a)的FCR显着低于LDL-APOB(0.39 [0.31,0.49]池/日,P = 0.03),相应的PR没有显着差异(14.80 [ 11.34,19.32] Vs 15.73 [11.93,20.75] Mg / kg /天,p = 0.80)。在LP(a)和LDL-apob的FCR和PR之间没有观察到显着的关联。结论LP(a)升高的患者,LP(a)的分解代谢比LDL-apob颗粒慢较慢,这意味着不同的代谢途径参与了这些脂蛋白的分解代谢。这些发现对新疗法进行了影响,用于降低载脂蛋白(A)并使αboOB以防止动脉粥样硬化心血管疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号